Drug pricing: Dems Kick Off Insulin Probe

Sanofi, Novo Nordisk and Eli Lilly have faced years of scrutiny over insulin prices, but their responses haven't satisfied two Democratic lawmakers who this week kicked off a fresh investigation into pricing for the products. The probe comes as drug pricing creates daily headlines in Washington, D.C., with lawmakers on both sides of the aisle debating potential solutions.